The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children

R. Bar-Yoseph, G. Livnat, Z. Schnapp, H. Dabbah, A. Goldbart, L. Bentur (Haifa, Beer Sheva, Israel)

Source: Annual Congress 2013 –Preschool wheeze
Session: Preschool wheeze
Session type: Thematic Poster Session
Number: 1159
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Bar-Yoseph, G. Livnat, Z. Schnapp, H. Dabbah, A. Goldbart, L. Bentur (Haifa, Beer Sheva, Israel). The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children. Eur Respir J 2013; 42: Suppl. 57, 1159

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Effect of vitamin d therapy on the pulmonary functions in pediatric asthma and allergic rhinitis
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014

Evaluation of vitamin D in asthma: Its effect on inflammatory markers and clinical profile
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016


Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Effect of roflumilast on airway remodeling in a murine model of chronic asthma
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma.
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

Montelukast improves air trapping, not airway remodeling, in moderate-to-severe patients with asthma: A pilot tudy
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015

Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016

Evaluation of vitamin D in bronchial asthma and its correlation with lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013